"ARDS is very much bigger than COVID-19 and will continue well beyond the time any vaccine becomes available for one of the many causes of ARDS."
I really think this is the kicker @Treed. COVID is all-consuming at the moment, and everyone is seeing everything through this lens (for many stocks - biotech, online retail, streaming). But one eye has to stay on the future and a world where COVID isn't king anymore. Surely.
The treatment's potential is huge. That's what's exciting.
COVID-19 ARDS and ARDS Share Price Scenarios, page-427
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 91.5¢ | $1.609M | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 131951 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 22000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |